Lifecome Biochemistry Co.,Ltd.

SZSE:002868.SZ

24.39 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

202320222021202020192018201720162015201420132012
Revenue 507.005329.85363.386308.145303.76344.292375.411401.49385.613295.776297.151306.556
Cost of Revenue 611.749339.104303.799214.62202.733225.382223.579243.989243.02210.348211.256204.065
Gross Profit -104.745-9.25459.58893.526101.027118.91151.832157.502142.59385.42885.894102.491
Gross Profit Ratio -0.207-0.0280.1640.3040.3330.3450.4040.3920.370.2890.2890.334
Reseach & Development Expenses 31.95821.82524.82119.91318.5514.56714.10713.17113.01611.77114.54411.719
General & Administrative Expenses 11.2445.9464.9855.3342.9993.0644.4343.4333.5052.36526.73121.188
Selling & Marketing Expenses 15.92610.81514.96911.88521.18620.82920.52822.23820.96916.44515.46416.408
SG&A 27.17116.76119.95417.21924.18423.89324.96225.6724.47418.8142.19437.595
Other Expenses 72.25912.10915.52712.6258.657-0.074-0.3117.8246.423.810.4581.67
Operating Expenses 131.38750.69560.30249.75751.39147.03546.62553.60751.24741.62344.09439.42
Operating Income -236.132-133.76-21.29148.02366.98587.197100.573104.3187.84932.86628.20248.617
Operating Income Ratio -0.466-0.406-0.0590.1560.2210.2530.2680.260.2280.1110.0950.159
Total Other Income Expenses Net -4.762-0.3510.7291.202-0.979-0.074-0.3113.9313.9593.74910.4581.67
Income Before Tax -240.893-134.11-32.3548.44266.00787.123100.263108.24191.80836.61538.65950.287
Income Before Tax Ratio -0.475-0.407-0.0890.1570.2170.2530.2670.270.2380.1240.130.164
Income Tax Expense -18.276-11.389-5.9065.5069.17512.43414.33815.8813.7045.1655.6897.047
Net Income -221.818-122.722-26.44443.20856.96674.68985.92592.36178.10531.44932.9743.241
Net Income Ratio -0.438-0.372-0.0730.140.1880.2170.2290.230.2030.1060.1110.141
EPS -1.44-0.8-0.170.280.370.480.60.790.670.270.280.37
EPS Diluted -1.44-0.8-0.170.280.370.480.60.790.670.270.280.37
EBITDA -127.925-53.71912.6579.87795.7691.749128.839113.437118.54374.03841.863.071
EBITDA Ratio -0.252-0.0130.0350.2720.3230.3470.3490.3560.340.2550.1440.222